Back to search

Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin b and an inhibitor of matrix metalloproteinases. evidence for two converging pathways of chondrocyte‐mediated proteoglycan degradation

Data up to Jan 2025

Published1993
Citations123
References39

Total Citations Per Year

Abstract

References (39)

Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue

1986 • 3,282 citations

L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L

1982 • 1,024 citations

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

1969 • 779 citations

A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases

1992 • 692 citations

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.

1986 • 496 citations

Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)

1991 • 454 citations

The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain.

1992 • 412 citations

Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues

1984 • 387 citations

A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.

1993 • 383 citations

Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).

1991 • 347 citations

The effect of hypervitaminosis A on embryonic limb‐bones cultivated in vitro

1952 • 316 citations

The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.

1992 • 297 citations

Degradation of collagen in the bone‐resorbing compartment underlying the osteoclast involves both cysteine‐proteinases and matrix metalloproteinases

1992 • 286 citations

Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain

1991 • 285 citations

Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitro

1991 • 271 citations

Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein

1984 • 262 citations

IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.

1990 • 242 citations

Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo

1991 • 213 citations

CA074 methyl ester: A proinhibitor for intracellular cathepsin B

1992 • 200 citations

Mechanism of catabolism of aggrecan by articular cartilage

1992 • 182 citations

In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64.

1986 • 175 citations

COMPARISON OF THE EFFECTS OF PAPAIN AND VITAMIN A ON CARTILAGE

1960 • 158 citations

Physiological mechanisms for metalloproteinase activation.

1992 • 142 citations

The degradation of cartilage matrix by an intracellular protease

1964 • 141 citations

IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.

1989 • 116 citations

Assay of Pyrogens by Interleukin-6 Release from Monocytic Cell Lines

1991 • 99 citations

Down-modulation of epidermal growth factor receptor affinity in fibroblasts treated with interleukin 1 or tumor necrosis factor is associated with phosphorylation at a site other than threonine 654.

1990 • 96 citations

Inhibition of cysteine proteinases in lysosomes and whole cells

1992 • 84 citations

Leucocyte infiltration and cartilage proteoglycan loss in immune arthritis in the rabbit

1988 • 71 citations

Murine interleukin‐1 receptor: Differences in binding properties between fibroblastic and thymoma cells and evidence for a two‐chain receptor model

1987 • 56 citations

Characterization of cathepsins in cartilage

1967 • 56 citations

Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidases

1992 • 54 citations

Inhibition by pepstatin of human cartilage degradation

1972 • 52 citations

Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.

1991 • 51 citations

THE IMMUNOCYTOCHEMICAL DEMONSTRATION OF CATHEPSIN D

1972 • 50 citations

A synthetic peptide metalloproteinase inhibitor, but not Timp, prevents the breakdown of proteoglycan within articular cartilagein vitro

1992 • 43 citations

Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation

1992 • 39 citations

Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro.

1987 • 32 citations

FLUSYS: a software package for the collection and analysis of kinetic and scanning data from Perkin-Elmer fluorimeters

1990 • 28 citations

Cited By (0)

No citing papers found in database

Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin b and… (1993) – Arthritis & Rheumatism | Metascience Observatory Explorer